The category of Tensin3 Inhibitors encompasses a broad spectrum of compounds that, rather than directly targeting Tensin3, aim to modulate the signaling pathways and cellular processes in which Tensin3 is involved. Given Tensin3's crucial role in integrating signals from the extracellular matrix to the actin cytoskeleton and its involvement in focal adhesion dynamics, the selected inhibitors focus on altering the cellular environment or signaling cascades that regulate Tensin3 expression or function. This approach leverages the interconnected nature of cellular signaling networks, targeting upstream or downstream factors that influence Tensin3 activity, including tyrosine kinases, PI3K, MAPKs, and integrins.
By focusing on compounds known to affect pathways critical for Tensin3's function, this strategy provides a means to explore the biological functions of Tensin3 and its role in essential cellular activities like migration, proliferation, and survival. The selection of these compounds not only facilitates a deeper understanding of Tensin3's involvement in cellular signaling but also exemplifies broader principles of drug action and the potential of targeted chemical intervention to modulate complex cellular functions. This methodology underscores the potential of pharmacological research to uncover novel strategies for diseases associated with aberrant Tensin3 activity, providing a foundation for further investigation into the mechanisms of action of Tensin3 and the development of new approaches to modulate its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, could disrupt signaling pathways involving Tensin3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, might affect downstream signaling pathways associated with Tensin3. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Broad-spectrum tyrosine kinase inhibitor, potentially affecting Tensin3's role in focal adhesion. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, could influence cytoskeletal reorganization and Tensin3's cellular functions. | ||||||
PF-562271 | 717907-75-0 | sc-478488 sc-478488A sc-478488B | 5 mg 10 mg 50 mg | $312.00 $474.00 $1124.00 | 3 | |
FAK inhibitor, might impact integrin signaling pathways relevant to Tensin3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially modulating pathways that influence Tensin3 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, could affect stress response pathways associated with Tensin3. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor, might impact MAPK/ERK signaling pathways involving Tensin3. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
PI3K inhibitor, could disrupt signaling cascades that modulate Tensin3 activity. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Integrin inhibitor, might indirectly affect Tensin3 by altering cell-matrix interactions. | ||||||